Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

United Arab Emirates · Delayed Price · Currency is AED

1.020

-0.020 (-1.92%)

At close: Sep 2, 2026

ADX:JULPHAR Financials Overview

Financials in millions AED. Fiscal year is January - December.

Millions AED. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,101	1,076	992.2	1,278	1,616	1,143
Revenue Growth	7.52%	8.39%	-22.33%	-20.95%	41.37%	99.51%
Gross Profit	476.3	435.9	407.1	425.1	557.9	383.4
Operating Income	94.4	54.2	46	-24.5	-28.6	41.5
Net Income	97	172.2	44.6	-99.1	-29.4	64.4
Earnings Per Share	0.08	0.15	0.04	-0.09	-0.03	0.06
EPS Growth	-45.29%	286.11%	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Manufacturing	900.4	913.1	814.7	794.4	886.4	699
Trading	463.9	432.6	416.7	-	-	-
Eliminations	-263	-270.2	-239.2	-223.6	-275.6	-
Total	1,101	1,076	992.2	1,278	1,616	1,143

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	344	268.6	168.6	225.3	111.8	178.8
Total Debt	273	275	971	1,111	885.7	819.1
Net Cash (Debt)	71	-6.4	-802.4	-885.3	-773.9	-640.3
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.06	-0.01	-0.69	-0.77	-0.67	-0.55

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	68.3	120.9	190	93.6	19.3	46.2
Capital Expenditures	-41.5	-35.7	-43.7	-22.1	-63.7	-44.4
Free Cash Flow	26.8	85.2	146.3	71.5	-44.4	1.8
Free Cash Flow Growth	-77.13%	-41.76%	104.61%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	43.25%	40.53%	41.03%	33.28%	34.52%	33.54%
Operating Margin	8.57%	5.04%	4.64%	-1.92%	-1.77%	3.63%
Pretax Margin	9.03%	4.41%	-0.67%	-5.46%	-2.07%	3.73%
Profit Margin	8.81%	16.01%	4.50%	-7.76%	-1.82%	5.63%
FCF Margin	2.43%	7.92%	14.74%	5.60%	-2.75%	0.16%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.39	7.85	33.67	-	-	33.01
Forward PE	9.27	21.27	52.00	57.00	21.09	16.64
P/FCF Ratio	43.97	15.86	10.27	12.43	-	1180.90
PS Ratio	1.07	1.26	1.51	0.70	0.83	1.86